Axcelis Stock After Doubling: Is It a Buy Right Now?
Axcelis Technologies has seen its stock surge this year, riding AI-chip demand. This guide breaks down what the compa...
Wondering what age you should start planning for retirement? Discover key insights that will help you prepare for a secure financial future.
25,645 articlesAxcelis Technologies has seen its stock surge this year, riding AI-chip demand. This guide breaks down what the compa...
Structure Therapeutics stock has surged after a major hedge fund increased its stake. This article breaks down what s...
A trading halt and a sharp drop put Lucid in the spotlight, but the company pushed back on bankruptcy chatter. This g...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
This week brought a notable rise for Corcept Therapeutics as investors reacted to a major catalyst. Learn what drove ...
As investors eye fastenal (FAST) 2026 earnings, the focus is on demand cycles, margin resilience, and cash flow stren...
A patient fund manager shows strong conviction, piling another $10 million into Turning Point Brands. The move highli...
Canopy Growth sits at the center of sharp investor debate. This article maps three plausible paths for the stock over...
Anterix stock surged 140% as a major investor disclosed a multi-million dollar buy. This article breaks down the driv...
Investors watch WWDC 2026 with high expectations as Apple readies a major AI push. This preview outlines what’s at st...
Fidelity's FTEC and Vanguard's VGT mirror the same U.S. tech index, but the subtle fee differences and fund mechanics...